Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × abiraterone × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 8 Prostatic Neoplasms, Castration-Resistant 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Bulbo-Spinal Atrophy, X-Linked 1 Bites and Stings 1

Interventions

Specimen Handling 6 Biopsy 6 decitabine and cedazuridine drug combination 2 Azacitidine 2 venetoclax 1 veliparib 1 ruxolitinib 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 iadademstat 1 fludarabine 1 fedratinib 1 axatilimab 1 Topotecan 1 Succimer 1 Pentetic Acid 1 Injections 1 Idarubicin 1 High-Energy Shock Waves 1 Granulocyte Colony-Stimulating Factor 1 Geritol 1 Edetic Acid 1 Decitabine 1 Cytarabine 1 Carboplatin 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡